2017
DOI: 10.1016/j.urology.2016.12.056
|View full text |Cite
|
Sign up to set email alerts
|

Antibiotic Coating of the Artificial Urinary Sphincter (AMS 800): Is it Worthwhile?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(11 citation statements)
references
References 29 publications
0
9
0
2
Order By: Relevance
“…In 2007, AMS introduced the InhibiZone‐coated AUS (rifampin and minocycline hydrochloride coating). Nevertheless, a recently published study showed that the antibiotic coating had no significant impact on infection or explantation rates in a retrospective cohort of 47 patients with InhibiZone and 258 without InhibiZone coating …”
Section: Summary Of Current Literaturementioning
confidence: 98%
“…In 2007, AMS introduced the InhibiZone‐coated AUS (rifampin and minocycline hydrochloride coating). Nevertheless, a recently published study showed that the antibiotic coating had no significant impact on infection or explantation rates in a retrospective cohort of 47 patients with InhibiZone and 258 without InhibiZone coating …”
Section: Summary Of Current Literaturementioning
confidence: 98%
“…For example, the AMS 800 implant has an antibiotic-impregnated coating (InhibiZone), with rifampin and minocycline. While this technology has shown increased efficacy in reducing infectious complications among PP implants, a recent retrospective analysis found no significant impact on infections or explantation rates in their multicenter cohort of 305 patients (12,21). A study by Adamsky et al also found that routine use of postoperative oral antibiotics does not reduce the odds of AUS explantations, and this practice should be reconsidered in the era of increasing bacterial resistance (22).…”
Section: Discussionmentioning
confidence: 98%
“…Due to the detriment and burden of this complication towards patients and the healthcare system, there has been significant efforts geared towards decreasing such risk for device infection. Meticulous attention to intraoperative sterile technique, implementation of antimicrobial adjuncts such as use of broad-spectrum intravenous antibiotics, irrigation lavage, and even use of antibiotic-impregnated AUS devices has been developed to decrease the risk of biofilm formation (11,12). Specific to revision procedures, studies from PP research by Henry et al have previously documented the importance of performing a thorough and vigorous washout of the implant space with antiseptic irrigation to dislodge any pre-existing biofilm that may have been sequestered during the initial implantation (13,14).…”
Section: Discussionmentioning
confidence: 99%
“…Последнее встречается менее чем у 2 % пациентов в медицинских центрах с большим практическим опытом внедрения ИМС [39]. По другим данным, применение ИМС с антибактериальным покрытием не продемонстрировало значительного эффекта в отношении протезной инфекции [12,40,41]. B. J. Linder и соавт.…”
Section: осложнения после имплантации искусственного мочевого сфинктераunclassified